Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $19.8 million versus the consensus estimate of $20.5 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.